Enfuvirtide Acetate CAS NO 159519-65-0 Inquire about Enfuvirtide Acetate
Tecoland supplies Enfuvirtide Acetate bulk active pharmaceutical ingredient (API) to the pharmaceutical industry. Our Enfuvirtide Acetate is manufactured by cGMP compliant facility. Welcome to contact us for further details including current DMF status for the product and up to date regulatory status of the manufacturing facility. We look forward to assisting you with your research and development projects.
| Product Name | Enfuvirtide Acetate (T-20) |
| Sequence | CH3CO-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu -Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn- Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys -Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2 |
| Cas No. | 159519-65-0 |
| Molecular Formula | C204H301N51O64 |
| Molecular Weight | 4492 |
| Purity (HPLC) | 98.0%min. |
| Appearance | White to off-white amorphous solid |
| Single Impurity (HPLC) |
0.5%max |
| Amino Acid Composition |
±10% of theoretical |
| Peptide Content (N%) |
≥80.0% |
| Water Content (Karl Fischer) |
≤8.0% |
| TrifluoroAcetate Content(HPIC) |
≤12.0% |
| MS (ESI) |
Consistent |
| Mass Balance | 95.0~105.0% |
Disclaimer:
Information on this page is provided for general information purposes. You should not make a clinical treatment decision based on information contained in this page without consulting other references including the package insert of the drug, textbooks and where relevant, expert opinion. We cannot be held responsible for any errors you make in administering drugs mentioned on this page, nor for use of any erroneous information contained on this page.